Tuesday, May 7, 2013

A deeper look at Flublok - the egg free vaccine

Recently, we invited Manon M.J. Cox, President and CEO, Protein Sciences Corporation to sit down with us before the Vaccines Development and Production Summit to give us a preview of the flu vaccine industry, what challenges their facing and the remarkable technology her company has developed in order to stand apart in the flu vaccine industry.

During the podcast, she discusses the difference between Flublok and other vaccines and the current perception of receiving a flu vaccine by many adults.  She also looks at the current influenza outbrake,t hat of H7N9 and how they've developed a plan to combat it with a vaccine.

Manon will be joining us at the Vaccines Development and Production Summit this June 3-5, 2013 in Durham, North Carolina.  For more information on her presentation Flublok®: Developing the World’s First Recombinant, Highly Purified, Egg-Free Influenza Vaccine and the rest of the program, download the agenda. As a reader of this blog when you register to join us and mention B13187SPX32, you'll save 20% off the standard rate. If you have any questiosn, feel free to reach out to Jennifer Pereira.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment